Silicon Therapeutics Company Profile

05:37 EDT 20th September 2019 | BioPortfolio

Silicon Therapeutics (“SiTX”) is a physics-driven drug discovery company focused on small molecule therapeutics for cancer that target innate immunity to “light the spark” within immunologically cold tumors. The company’s unique computational physics-based platform can accurately simulate the physical motion and properties of biological targets at atomistic resolution to reveal unique insights into the drug design process. The platform is cohesively integrated with a world-class wet lab including biophysics, chemistry, and biology to enable rapid hypothesis-driven data generation to advance drug discovery projects on targets that have traditionally been thought of as undruggable. The SiTX lead program is a small molecule STING agonist for systemic delivery in I/O that is slated to enter the clinic in mid-2020. The company’s headquarters and laboratories are in Boston, MA with additional operations in Suzhou, China.

News Articles [1065 Associated News Articles listed on BioPortfolio]

Biocompatibility between Silicon or Silicon Carbide surface and Neural Stem Cells

Elkem Buys South Korea’s Basel Chemie

Norwegian silicon producer Elkem is buying Basel Chemie, a South Korean producer of specialty silicon gels, for $26.9 million. Elkem said the deal gives it access to leading technology in attractive e...

Medical News Today: What to know about silicon dioxide

Silicon dioxide is a food additive. It is generally safe and occurs in many leafy greens and other vegetables. Inhaling fine particles may cause adverse effects. Learn more here.

Lasers and Silicon Offer a Glimpse into the Future

NewsResearch group develops a high-performance quantum dot mode-locked laser on silicon.Contributed Author: 

Expanding the Use of Silicon in Batteries, by Preventing Electrodes From Expanding

NewsAn injection of MXene ink fortifies silicon anodes to absorb charge without terminal swelling.Contributed Author: 

Axsome Therapeutics Amends Silicon Valley Bank Loan Agreement Increasing Financial Flexibility

Extends interest-only period and time to access additional funding NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) Read more...

Quantum World-First: Researchers Reveal Accuracy of Two-Qubit Calculations in Silicon

NewsFor the first time ever, researchers have measured the fidelity of two-qubit logic operations in silicon, with highly promising results.

Silicon Is Reaching its Limits. Up Next: Carbon Nanotubes

Silicon has powered the information age, but it’s reaching its physical limits. Carbon nanotubes (CNTs) hold a lot of promise as a replacement if we can get around some key obstacles—and the desig...

Drugs and Medications [29 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [657 Associated PubMed Articles listed on BioPortfolio]

Largely Improved Battery Performance Using Micro-Sized Silicon Skeleton Caged By Polypyrrole As Anode.

Various architectures with nano-structured silicon have demonstrated promising battery performance while posing a challenge in industrial production. The current ratio of silicon in graphite as anode ...

Surface deep profile synchrotron studies of mechanically modified top-down silicon nanowires array using ultrasoft X-ray absorption near edge structure spectroscopy.

Atomic, electronic structure and composition of top-down metal-assisted wet-chemically etched silicon nanowires were studied by synchrotron radiation based X-ray absorption near edge structure techniq...

Laser induced breakdown optical emission spectroscopic study of silicon plasma.

The laser induced breakdown optical emission spectroscopy technique has been employed for the analysis of silicon sample in the atmospheric air. Laser irradiance of 1 × 10 Wcm was created on spec...

Topical monomethylsilanetriol can deliver silicon to the viable skin.

Organic silicon has been linked to positive effects on the skin rejuvenation, mainly by the oral route. Thus, the main objective of the present study was to assess whether monomethylsilanetriol (MMST,...

Scalable synthesis of ant-nest-like bulk porous silicon for high-performance lithium-ion battery anodes.

Although silicon is a promising anode material for lithium-ion batteries, scalable synthesis of silicon anodes with good cyclability and low electrode swelling remains a significant challenge. Herein,...

Clinical Trials [223 Associated Clinical Trials listed on BioPortfolio]

Efficacy Study of Two Silicon-based Products to Treat Scars

This study aims to determine if a silicon-based gel and a silicon-based aerosol are effective in the treatment of postoperative scars.

Displacement Between PVC and Silicon DLT

The purpose of this study is to compare difference of displacement between Polyvinyl Chloride(PVC) and Silicon double-lumen endobronchial tubes(DLTs) during changing position from supine t...

Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women

The aim of this research study is to determine by laboratory analyses the effects of drinking silicon-rich water on bone health. This will be determined from blood and urine samples from ...

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

This phase I trial studies the side effects and best dose of silicon phthalocyanine 4 and photodynamic therapy in treating patients with stage IA-IIA cutaneous T-cell non-Hodgkin lymphoma....

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Photodynamic therapy using s...

Companies [1573 Associated Companies listed on BioPortfolio]

Silicon Labs

Silicon Labs is an industry leader in the innovation of high-performance, analog-intensive, mixed-signal ICs. Developed by a world-class engineering team with unsurpassed expertis...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the D...

Silicon Therapeutics

Silicon Therapeutics (“SiTX”) is a physics-driven drug discovery company focused on small molecule therapeutics for cancer that target innate immunity to “light the spark” within ...

Luma Therapeutics

Based in Silicon Valley, Luma Therapeutics is a privately held medical technology company committed to developing innovative and convenient therapies for the millions of people ar...

Qool Therapeutics, Inc.

Qool Therapeutics, Inc., based in Silicon Valley, is dedicated to creating non-invasive, efficient temperature management therapies to preserve cells, slow inflammation, and impro...

More Information about "Silicon Therapeutics" on BioPortfolio

We have published hundreds of Silicon Therapeutics news stories on BioPortfolio along with dozens of Silicon Therapeutics Clinical Trials and PubMed Articles about Silicon Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Silicon Therapeutics Companies in our database. You can also find out about relevant Silicon Therapeutics Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record